Limited upside potential for vaccine plays

It seems that much of the upside for the vaccine play has been priced in. Cannot see very much more, other than one getting luckier than the other. It is a horse race right now, they are all neck and neck it seems. Astrazenica, which is not included, may be ahead right now; but not for long it seems.